<DOC>
	<DOCNO>NCT00495573</DOCNO>
	<brief_summary>The purpose study evaluate pattern viral shed begin treatment acyclovir clinical recurrence genital herpes compare pattern viral shed untreated clinical recurrence genital herpes .</brief_summary>
	<brief_title>HSV-2 Shedding Resolution After Acyclovir Treatment</brief_title>
	<detailed_description>The purpose study evaluate pattern viral shed begin treatment acyclovir clinical recurrence genital herpes compare pattern viral shed untreated clinical recurrence genital herpes . Participants ask visit University Washington Virology Research Clinic initial screen appointment clinician ensure eligibility inform consent obtain . Participants experience outbreak next year ask call clinic begin next outbreak . The clinician arrange admit participant UW General Clinical Research Center ( GCRC ) 5-day hospitalization stay . During hospitalization , participant take acyclovir ( 400mg 3 time daily ) genital swab collect every 2 hour day every 4 hour night 5 day . After last swab take , study nurse GCRC final genital exam participant discharge . Some participant also ask enroll control arm procedure follow except take acyclovir recurrence .</detailed_description>
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Age 18 year old History clinicallyevident genital herpes 3 clinical genital herpes recurrence within prior 12 month HSV2 seropositive HSV Western Blot Willing able comply study protocol Pregnancy Taking daily antiviral therapy genital herpes HIV seropositive know immunocompromising medical condition Plan move Seattle area within next year Hypersensitivity intolerance acyclovir</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>